REBECCA BRISCO: Open Payments
NPI 1780780619 · COQUILLE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$109 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $109
Food & beverage: $109
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $31 |
| Pacira Pharmaceuticals Incorporated | 1 | $31 |
| Madrigal Pharmaceuticals | 1 | $26 |
| BioCryst US Sales Co., LLC | 1 | $21 |
Products named: AREXVY, Exparel, REZDIFFRA, ORLADEYO.
Industry payments across OR — which companies pay providers there.
